<DOC>
	<DOC>NCT00660803</DOC>
	<brief_summary>Characterize the demographic and clinical features, as well as the main treatment results, among patients with advanced breast cancer treated with fulvestrant in Brazil.</brief_summary>
	<brief_title>Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Positive HR or ER by immunohistochemistry Postmenopausal status at the time of treatment with fulvestrant Failure of at least one previous endocrine therapy before treatment with fulvestrant. Patients who are still undergoing treatment with fulvestrant will not be eligible to participate in the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Advanced Breast Cancer</keyword>
	<keyword>Hormone Therapy</keyword>
</DOC>